ImmunoGen
IMGN
#2203
Rank
A$12.64 B
Marketcap
A$45.27
Share price
0.00%
Change (1 day)
121.67%
Change (1 year)

ImmunoGen (IMGN) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : A$0.37 Billion

According to ImmunoGen 's latest financial reports the company's total liabilities are A$0.37 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ImmunoGen - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.28 B2.77%
2021-12-31A$0.27 B-20.03%
2020-12-31A$0.34 B-22.36%
2019-12-31A$0.44 B10.16%
2018-12-31A$0.40 B0.84%
2017-12-31A$0.40 B
2016-06-30A$0.48 B36.72%
2015-06-30A$0.35 B273.53%
2014-06-30A$95.04 M-5.43%
2013-06-30A$0.10 B6.76%
2012-06-30A$94.13 M29.9%
2011-06-30A$72.46 M74.58%
2010-06-30A$41.5 M-0.78%
2009-06-30A$41.83 M42.71%
2008-06-30A$29.31 M12.74%
2007-06-30A$26 M-11.67%
2006-06-30A$29.44 M-3.54%
2005-06-30A$30.52 M-17.31%
2004-06-30A$36.91 M60.56%
2003-06-30A$22.98 M-28.07%
2002-06-30A$31.96 M-2.14%
2001-06-30A$32.66 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$173.51 B 45,852.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$115.38 B 30,457.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$169.90 B 44,894.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$123.75 B 32,674.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$120.76 B 31,881.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$92.07 B 24,283.56%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$96.20 B 25,378.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A$1.57 B 316.05%๐Ÿ‡บ๐Ÿ‡ธ USA